NT
NTLA
Intellia Therapeutics, Inc. - Common Stock
NASDAQMarket Cap
P/E Ratio
11.53
Dividend Yield
3.53%
Volume
52W High
52W Low
Avg Volume
Financial Statements
What does this mean?Income statement, balance sheet, and cash flow over time
| Metric | |
|---|---|
No financial data available
Institutional Ownership
What does this mean?Top institutions holding NTLA
| Institution | Shares Held | Value | Date |
|---|---|---|---|
| Vanguard Group | 150,000,000 | $25,000,000,000 | Oct 2025 |
| BlackRock | 140,000,000 | $23,500,000,000 | Oct 2025 |
| State Street | 80,000,000 | $13,500,000,000 | Oct 2025 |
| Fidelity | 65,000,000 | $11,000,000,000 | Oct 2025 |
| Geode Capital | 35,000,000 | $5,900,000,000 | Nov 2025 |
ETF Holdings
What does this mean?Top ETFs holding NTLA
| ETF | Weight | Shares |
|---|---|---|
| QQQ | 8.50% | 21,061,555 |
| VGT | 6.20% | 47,805,083 |
| SPY | 4.50% | 30,915,748 |
| IVV | 4.20% | 10,489,063 |
| VOO | 3.80% | 39,577,338 |
Trade
Buy/Sell via broker links (affiliate).
Trading 212
Paper Trade
Save a buy/sell to your portfolio tracker (not a real trade).
Sign in
to save trades to your portfolio tracker.
Paper Orders
Limit/stop reminders, with optional bracket (take profit + stop loss).
Sign in
to place paper orders.
Price Alerts
Notify when NTLA crosses your target.
Sign in
to create alerts and sync them across devices.
Company Info
What does this mean?About
Intellia Therapeutics, Inc. - Common Stock (NTLA) is included in the Stock Monitor database for research and watchlists.
CEO
N/A
Employees
91,353
IPO Date
Jan 1, 2000
Analyst Ratings
What does this mean?Piper Sandler
Dec 6, 2025
Buy
Goldman Sachs
Nov 14, 2025
Hold
Morgan Stanley
Oct 28, 2025
Hold
JPMorgan
Oct 11, 2025
Overweight
Bernstein
Sep 24, 2025
Buy
Price Target
$375.85